| Trial ID: | L5764 |
| Source ID: | NCT05741437
|
| Associated Drug: |
Ckd-378, Qd, Po Drug: D745, D150, Qd, Po
|
| Title: |
A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type II Diabetes
|
| Interventions: |
DRUG: CKD-378, QD, PO Drug: D745, D150, QD, PO
|
| Outcome Measures: |
Primary: 1. AUCt of CKD-378: Area under the concentration-time curve time zero to time, Pre-dose(0 hour) to 48 hours|2. Cmax of CKD-378: Maximum plasma concentration of the drug, Pre-dose(0 hour) to 48 hours |
|
| Sponsor/Collaborators: |
Sponsor: Chong Kun Dang Pharmaceutical
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
24
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2023-04-11
|
| Completion Date: |
2023-09-05
|
| Results First Posted: |
|
| Last Update Posted: |
2024-03-12
|
| Locations: |
Severance Hospital, Seoul, Seodaemun-gu, 03722, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT05741437
|
